Overview
Maki Tobari practices in Tokyo, Japan. Tobari is highly rated in 2 conditions, according to our data. Their top areas of expertise are Non-Alcoholic Fatty Liver Disease, Cholangitis, Liver Cancer, and Sepsis.
Their clinical research consists of co-authoring 17 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- CholangitisTobari isAdvanced. Learn about Cholangitis.
- Non-Alcoholic Fatty Liver Disease
- Experienced
- CirrhosisTobari isExperienced. Learn about Cirrhosis.
- HepatitisTobari isExperienced. Learn about Hepatitis.
- Liver CancerTobari isExperienced. Learn about Liver Cancer.
- Nonalcoholic Steatohepatitis (NASH)
- ObesityTobari isExperienced. Learn about Obesity.
- SepsisTobari isExperienced. Learn about Sepsis.